当前位置:
X-MOL 学术
›
Lancet Infect Dis
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Vaccine against Zika virus must remain a priority
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2017-10-01 , DOI: 10.1016/s1473-3099(17)30534-0 The Lancet Infectious Diseases
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2017-10-01 , DOI: 10.1016/s1473-3099(17)30534-0 The Lancet Infectious Diseases
On Sept 1, the pharmaceutical company Sanofi Pasteur announced that it was withdrawing from development of a vaccine against Zika virus infection. This announcement raises concerns about the future of Zika virus vaccine development, at a time when the number of cases is falling and other questions about the virus remain unanswered.
中文翻译:
寨卡病毒疫苗必须保持优先地位
9月1日,制药公司赛诺菲巴斯德(Sanofi Pasteur)宣布,其正在开发针对寨卡病毒感染的疫苗。这一宣布引起人们对寨卡病毒疫苗开发的未来的担忧,当时病例数正在下降,有关该病毒的其他问题仍未得到解答。
更新日期:2017-09-20
中文翻译:
寨卡病毒疫苗必须保持优先地位
9月1日,制药公司赛诺菲巴斯德(Sanofi Pasteur)宣布,其正在开发针对寨卡病毒感染的疫苗。这一宣布引起人们对寨卡病毒疫苗开发的未来的担忧,当时病例数正在下降,有关该病毒的其他问题仍未得到解答。